Pharmaceutical: Tamsulosin (36C77024Q0292)
Waiver type - Procurement: Nonavailability
Agency: VETERANS AFFAIRS, DEPARTMENT OF (3600) • Product Service Code (PSC) : 6505 | Last Modified: 11/06/2024
Procurement Summary
VHA RPO-C/CMOP intends to procure Tamsulosin HCL for VA CMOPs. This procurement was solicited via 36C77024Q0292 as a competitive SDVOSB set-aside. This procurement is not subject to the Trade Agreements Act due to it being set aside for SDVOSBs. Tamsulosin HCL is an alpha1 adrenoceptor antagonist indicated for treatment of the signs and symptoms of benign prostatic hyperplasia. This prescription is supplied to the CMOP, which provides direct mail order pharmacy services to Veterans and beneficiaries throughout the U.S. This is a onetime purchase with monthly deliveries for six (6) months.
Waiver Rationale Summary
In accordance with FAR 25.401(a)(1), this procurement is not subject to Trade Agreements, as the procurement was set aside for Service Disabled Veteran Owned Small Businesses (SDVOSBs). Although the Buy American Act is applicable to small business set-asides (FAR 25.101(b)), the VA is exercising an exception to the Buy American Act (FAR 25.103(b) - Nonavailability) by utilizing a foreign manufacturer. The amended solicitation was evaluated using a lowest priced technically acceptable evaluation approach and not comparative analysis. No domestic sources were discovered during market research. Additionally, no quotes for domestic end items were received in response to the solicitation.
Yes
No
Consistent with Policy
DRUGS AND BIOLOGICALS
325412 - Pharmaceutical Preparation Manufacturing
11/04/2024
36C77024Q0292
36C77024Q0292
Post-solicitation
0 - 6 months
Individual Waiver
VETERANS AFFAIRS, DEPARTMENT OF